Condition: Liver Cancer (Locally Advanced or Metastatic) · Lung Cancer (NSCLC) · Head and Neck Cancer Squamous Cell Carcinoma · Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Evaluate the efficacy and safety of SH009 injection therapy for patients with advanced solid tumors
This description comes directly from the study's public registry record.
Jie Min · 86-15121121360 · minjie@sanhome.com
Always discuss trial participation with your own doctor first.
| Shanghai Gaobo Cancer Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07390838